Report Detail
Global DNA Vaccines Market Growth 2019-2024
- RnM3181970 |
- 25 March, 2019 |
- Global |
- 132 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
North America is the largest consumption place, with a revenue market share nearly 58% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 28% in 2017. Asia-Pacific is also an important sales area, especially in China.
According to this study, over the next five years the DNA Vaccines market will register a 8.3% CAGR in terms of revenue, the global market size will reach US$ 5490 million by 2024, from US$ 3690 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in DNA Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Vaccines market by product type, application, key manufacturers and key regions and countries.
This study considers the DNA Vaccines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Recombinant Protein Vaccine
Gene-Based Vaccine
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Human
Animal
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global DNA Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of DNA Vaccines market by identifying its various subsegments.
Focuses on the key global DNA Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the DNA Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of DNA Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global DNA Vaccines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global DNA Vaccines Consumption 2014-2024
- 2.1.2 DNA Vaccines Consumption CAGR by Region
- 2.2 DNA Vaccines Segment by Type
- 2.2.1 Recombinant Protein Vaccine
- 2.2.2 Gene-Based Vaccine
- 2.3 DNA Vaccines Consumption by Type
- 2.3.1 Global DNA Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global DNA Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global DNA Vaccines Sale Price by Type (2014-2019)
- 2.4 DNA Vaccines Segment by Application
- 2.4.1 Human
- 2.4.2 Animal
- 2.5 DNA Vaccines Consumption by Application
- 2.5.1 Global DNA Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global DNA Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global DNA Vaccines Sale Price by Application (2014-2019)
3 Global DNA Vaccines by Players
- 3.1 Global DNA Vaccines Sales Market Share by Players
- 3.1.1 Global DNA Vaccines Sales by Players (2017-2019)
- 3.1.2 Global DNA Vaccines Sales Market Share by Players (2017-2019)
- 3.2 Global DNA Vaccines Revenue Market Share by Players
- 3.2.1 Global DNA Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global DNA Vaccines Revenue Market Share by Players (2017-2019)
- 3.3 Global DNA Vaccines Sale Price by Players
- 3.4 Global DNA Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global DNA Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players DNA Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 DNA Vaccines by Regions
- 4.1 DNA Vaccines by Regions
- 4.1.1 Global DNA Vaccines Consumption by Regions
- 4.1.2 Global DNA Vaccines Value by Regions
- 4.2 Americas DNA Vaccines Consumption Growth
- 4.3 APAC DNA Vaccines Consumption Growth
- 4.4 Europe DNA Vaccines Consumption Growth
- 4.5 Middle East & Africa DNA Vaccines Consumption Growth
5 Americas
- 5.1 Americas DNA Vaccines Consumption by Countries
- 5.1.1 Americas DNA Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas DNA Vaccines Value by Countries (2014-2019)
- 5.2 Americas DNA Vaccines Consumption by Type
- 5.3 Americas DNA Vaccines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC DNA Vaccines Consumption by Countries
- 6.1.1 APAC DNA Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC DNA Vaccines Value by Countries (2014-2019)
- 6.2 APAC DNA Vaccines Consumption by Type
- 6.3 APAC DNA Vaccines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe DNA Vaccines by Countries
- 7.1.1 Europe DNA Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe DNA Vaccines Value by Countries (2014-2019)
- 7.2 Europe DNA Vaccines Consumption by Type
- 7.3 Europe DNA Vaccines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa DNA Vaccines by Countries
- 8.1.1 Middle East & Africa DNA Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa DNA Vaccines Value by Countries (2014-2019)
- 8.2 Middle East & Africa DNA Vaccines Consumption by Type
- 8.3 Middle East & Africa DNA Vaccines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 DNA Vaccines Distributors
- 10.3 DNA Vaccines Customer
11 Global DNA Vaccines Market Forecast
- 11.1 Global DNA Vaccines Consumption Forecast (2019-2024)
- 11.2 Global DNA Vaccines Forecast by Regions
- 11.2.1 Global DNA Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global DNA Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global DNA Vaccines Forecast by Type
- 11.8 Global DNA Vaccines Forecast by Application
12 Key Players Analysis
- 12.1 Merck
- 12.1.1 Company Details
- 12.1.2 DNA Vaccines Product Offered
- 12.1.3 Merck DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Merck News
- 12.2 GSK
- 12.2.1 Company Details
- 12.2.2 DNA Vaccines Product Offered
- 12.2.3 GSK DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 GSK News
- 12.3 Sanofi
- 12.3.1 Company Details
- 12.3.2 DNA Vaccines Product Offered
- 12.3.3 Sanofi DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Sanofi News
- 12.4 Zoties
- 12.4.1 Company Details
- 12.4.2 DNA Vaccines Product Offered
- 12.4.3 Zoties DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Zoties News
- 12.5 Elanco
- 12.5.1 Company Details
- 12.5.2 DNA Vaccines Product Offered
- 12.5.3 Elanco DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Elanco News
- 12.6 Boehringer-Ingelheim
- 12.6.1 Company Details
- 12.6.2 DNA Vaccines Product Offered
- 12.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Boehringer-Ingelheim News
- 12.7 Indian Immunologicals
- 12.7.1 Company Details
- 12.7.2 DNA Vaccines Product Offered
- 12.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Indian Immunologicals News
- 12.8 Plumbline Life Sciences
- 12.8.1 Company Details
- 12.8.2 DNA Vaccines Product Offered
- 12.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Plumbline Life Sciences News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on DNA Vaccines. Industry analysis & Market Report on DNA Vaccines is a syndicated market report, published as Global DNA Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of DNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
